Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 6, 2023
Pyrolyzed
deketene
curcumin
GO-Y022
prevents
carcinogenesis
in
a
gastric
cancer
mouse
model.
However,
it
is
still
less
clear
if
affects
tumor-induced
immune
suppression.
In
this
study,
we
found
that
inhibited
Treg
generation
the
presence
of
transforming
growth
factor
beta
1
(TGF-β).
showed
impact
on
Foxp3+
Tregs
tumor
microenvironment.
Gastric
cells
produce
large
amount
L-lactate
and
diminish
inhibitory
role
against
response
to
TGF-β.
Therefore,
naïve
CD4+
T
co-cultured
with
treated
increased
generation.
GO-Y022-induced
cell
death
was
further
enhanced
by
2-deoxy-d-glucose
(2DG),
glycolysis
inhibitor.
Combination
treatment
2DG
results
reduced
production
cells.
Overall,
GO-Y022-treatment
restricted
glucose
metabolism
inhibits
survival
promotes
anti-tumor
immunity.
Frontiers in Oncology,
Journal Year:
2020,
Volume and Issue:
10
Published: Oct. 7, 2020
During
tumorigenesis,
cancer
cells
are
exposed
to
a
wide
variety
of
intrinsic
and
extrinsic
stresses
that
challenge
homeostasis
growth.
Cancer
display
activation
distinct
mechanisms
for
adaptation
growth
even
in
the
presence
stress.
Autophagy
is
catabolic
mechanism
aides
degradation
damaged
intracellular
material
metabolite
recycling.
This
activity
helps
meet
metabolic
needs
during
nutrient
deprivation,
genotoxic
stress,
factor
withdrawal
hypoxia.
However,
autophagy
plays
paradoxical
role
depending
on
stage
tumor
development.
Early
suppressor
via
potentially
oncogenic
molecules.
advanced
stages,
promotes
survival
by
ameliorating
stress
microenvironment.
These
roles
intricate
due
their
interconnection
with
other
cellular
pathways.
In
this
review,
we
present
broad
view
participation
phases
Moreover,
important
processes
such
as
cell
death,
reprogramming,
metastasis,
immune
evasion
treatment
resistance
all
contribute
development,
reviewed.
Finally,
contribution
hypoxic
deficient
microenvironment
regulation
these
hallmarks
development
more
aggressive
tumors
discussed.
Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
11
Published: Sept. 3, 2021
Although
chemotherapy
can
improve
the
overall
survival
and
prognosis
of
cancer
patients,
chemoresistance
remains
an
obstacle
due
to
diversity,
heterogeneity,
adaptability
environmental
alters
in
clinic.
To
determine
more
possibilities
for
therapy,
recent
studies
have
begun
explore
changes
metabolism,
especially
glycolysis.
The
Warburg
effect
is
a
hallmark
that
refers
preference
cells
metabolize
glucose
anaerobically
rather
than
aerobically,
even
under
normoxia,
which
contributes
chemoresistance.
However,
association
between
glycolysis
molecular
mechanisms
glycolysis-induced
unclear.
This
review
describes
mechanism
from
aspects
process,
signaling
pathways,
tumor
microenvironment,
their
interactions.
understanding
how
induces
may
provide
new
targets
concepts
therapy.
Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(2), P. 234 - 234
Published: Feb. 3, 2023
Inducing
cancer
cell
death
has
always
been
a
research
hotspot
in
life
sciences.
With
the
continuous
deepening
and
diversification
of
related
research,
potential
value
metal
elements
inducing
explored.
Taking
iron
as
an
example,
ferroptosis,
mainly
characterized
by
increasing
load
driving
production
large
amounts
lipid
peroxides
eventually
leading
to
death,
recently
attracted
great
interest
community.
After
iron,
copper,
trace
element,
received
extensive
attention
especially
tumor
death.
Copper
its
complexes
can
induce
autophagy
or
apoptosis
cells
through
variety
different
mechanisms
action
(activation
stress
pathways,
arrest
cycle,
inhibition
angiogenesis,
cuproptosis,
paraptosis),
which
are
promising
therapy
have
become
new
hotspots
treatment
research.
This
article
reviews
main
applications
novel
copper
compound-induced
focusing
on
compounds
their
anticancer
applications.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(4)
Published: April 20, 2022
Metabolic
disorders
and
abnormal
immune
function
changes
occur
in
tumor
tissues
cells
to
varying
degrees.
There
is
increasing
evidence
that
reprogrammed
energy
metabolism
contributes
the
development
of
suppressive
microenvironment
influences
course
gastric
cancer
(GC).
Current
studies
have
found
(TME)
also
has
important
clinicopathological
significance
predicting
prognosis
therapeutic
efficacy.
Novel
approaches
targeting
TME
therapy,
such
as
checkpoint
blockade
(ICB),
metabolic
inhibitors
key
enzymes
metabolism,
been
involved
treatment
GC.
However,
interaction
between
GC
how
make
better
use
these
immunotherapy
methods
complex
are
still
being
explored.
Here,
we
discuss
reprogramming
responses
modulate
anti-tumor
responses,
well
effects
gastrointestinal
flora
It
proposed
enhance
response
by
understanding
targeted
provide
direction
for
iScience,
Journal Year:
2022,
Volume and Issue:
25(7), P. 104630 - 104630
Published: June 17, 2022
Cancer
cells
tend
to
utilize
aerobic
glycolysis
generate
energy
and
metabolites;
the
end
product
of
is
lactate,
which
promotes
lysine
lactylation
(Kla).
Kla
a
newly
discovered
histone
post-translational
modification
(PTM)
that
plays
important
roles
in
regulating
gene
expression.
However,
non-histone
mammalian
proteins
unclear.
Here,
comprehensive
analysis
lactylated
gastric
cancer
AGS
was
conducted.
There
were
2375
sites
found
1014
proteins.
Interestingly,
KEGG
pathway
showed
these
significantly
enriched
spliceosome
function.
In
addition,
more
abundant
tumors
than
adjacent
tissues,
high
levels
associated
with
poor
prognosis.
These
results
suggest
could
be
prognostic
marker
cancer.
This
lactylome
cells,
first
its
kind,
provides
valuable
foundation
for
further
studies
Kla.
Bioengineered,
Journal Year:
2022,
Volume and Issue:
13(5), P. 13906 - 13918
Published: May 2, 2022
The
active
ingredient
of
the
traditional
Chinese
medicine
comfrey
is
shikonin,
a
naphthoquinone
compound.
focus
this
study
was
to
investigate
effect
shikonin
on
proliferation,
invasion,
migration,
and
chemoresistance
non-small
cell
lung
cancer
(NSCLC)
cells,
explore
its
underlying
molecular
biological
mechanisms.
results
show
that
inhibited
viability,
migration
NSCLC
cells
A549
PC9,
induced
apoptosis.
As
inhibitor
pyruvate
kinase
M2
(PKM2),
key
enzyme
in
glycolysis,
glucose
uptake
production
lactate,
final
metabolite
aerobic
glycolysis.
In
vivo
chemotherapeutic
assay
showed
reduced
tumor
volume
weight
mice
model
increased
sensitivity
cisplatin
chemotherapy.
Histoimmunology
experiments
combination
downregulated
expression
PKM2
transcriptionally
regulated
downstream
gene
transporter
1
(Glut1)
tissue.
an
assessment
metabolism,
micro-PET/CT
data
fluorodeoxy
(18F-FDG)
into
tumor.
Since
exosomal
affected
we
also
demonstrated
could
inhibit
exosome
secretion
through
administration
GW4869.
Furthermore,
sensitized
treatment
by
reducing
extracellular
PKM2.
conclusion,
suggest
not
only
inhibits
intracellularly
but
reduces
glycolytic
flux
increases
pathway.
Frontiers in Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: Oct. 29, 2021
Acute
and
chronic
kidney
disease
are
responsible
for
large
healthcare
costs
worldwide.
During
injury,
metabolism
undergoes
profound
modifications
in
order
to
adapt
oxygen
nutrient
shortage.
Several
studies
highlighted
recently
the
importance
of
these
metabolic
adaptations
acute
as
well
phases
renal
disease,
with
a
potential
deleterious
effect
on
fibrosis
progression.
Until
recently,
glucose
has
been
poorly
studied,
even
though
capacity
use
produce
glucose,
depending
segment
nephron.
physiology,
proximal
tubular
cells
beta-oxidation
fatty
acid
generate
amounts
energy,
can
also
through
gluconeogenesis.
In
undergo
shift,
shifting
away
from
acids
gluconeogenesis
toward
glycolysis.
loss
oxidation
is
well-described,
data
about
emerging.
We
here
review
during
their
consequences,
therapeutic
implications.